MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Clinical trial NCT04762199 · RECRUITING

Trial details

NCT number: NCT04762199
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Lung Non-Small Cell Carcinoma Metastatic Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8

Start date: 2021-02-24
Primary completion: 2026-12-27
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.